Lesniak MS - Search Results

1

Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma.

Spencer D, Yu D, Morshed RA, Li G, Pituch KC, Gao DX, Bertolino N, Procissi D, Lesniak MS, Balyasnikova IV. Spencer D, et al. Among authors: lesniak ms. Theranostics. 2019 Apr 6;9(7):2071-2083. doi: 10.7150/thno.29581. eCollection 2019. Theranostics. 2019. PMID: 31037157 Free PMC article.

2

Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma.

Sonabend AM, Ulasov IV, Tyler MA, Rivera AA, Mathis JM, Lesniak MS. Sonabend AM, et al. Among authors: lesniak ms. Stem Cells. 2008 Mar;26(3):831-41. doi: 10.1634/stemcells.2007-0758. Epub 2008 Jan 10. Stem Cells. 2008. PMID: 18192232

3

Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.

Tyler MA, Ulasov IV, Sonabend AM, Nandi S, Han Y, Marler S, Roth J, Lesniak MS. Tyler MA, et al. Among authors: lesniak ms. Gene Ther. 2009 Feb;16(2):262-78. doi: 10.1038/gt.2008.165. Epub 2008 Dec 11. Gene Ther. 2009. PMID: 19078993 Free PMC article.

4

Virotherapy against malignant glioma stem cells.

Dey M, Ulasov IV, Lesniak MS. Dey M, et al. Among authors: lesniak ms. Cancer Lett. 2010 Mar 1;289(1):1-10. doi: 10.1016/j.canlet.2009.04.045. Epub 2009 Jul 29. Cancer Lett. 2010. PMID: 19643532 Free PMC article. Review.

5

A chimeric adenovirus with an Ad 3 fiber knob modification augments glioma virotherapy.

Nandi S, Ulasov IV, Rolle CE, Han Y, Lesniak MS. Nandi S, et al. Among authors: lesniak ms. J Gene Med. 2009 Nov;11(11):1005-11. doi: 10.1002/jgm.1385. J Gene Med. 2009. PMID: 19688792 Free PMC article.

6

Stem cells as delivery vehicles for oncolytic adenoviral virotherapy.

Kranzler J, Tyler MA, Sonabend AM, Ulasov IV, Lesniak MS. Kranzler J, et al. Among authors: lesniak ms. Curr Gene Ther. 2009 Oct;9(5):389-95. doi: 10.2174/156652309789753347. Curr Gene Ther. 2009. PMID: 19860653 Free PMC article. Review.

7

Genetic modification of mesenchymal stem cells to express a single-chain antibody against EGFRvIII on the cell surface.

Balyasnikova IV, Franco-Gou R, Mathis JM, Lesniak MS. Balyasnikova IV, et al. Among authors: lesniak ms. J Tissue Eng Regen Med. 2010 Jun;4(4):247-58. doi: 10.1002/term.228. J Tissue Eng Regen Med. 2010. PMID: 19937911 Free PMC article.

8

Cancer stem cells: the final frontier for glioma virotherapy.

Dey M, Ulasov IV, Tyler MA, Sonabend AM, Lesniak MS. Dey M, et al. Among authors: lesniak ms. Stem Cell Rev Rep. 2011 Mar;7(1):119-29. doi: 10.1007/s12015-010-9132-7. Stem Cell Rev Rep. 2011. PMID: 20237963 Free PMC article. Review.

9

Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma.

Balyasnikova IV, Ferguson SD, Sengupta S, Han Y, Lesniak MS. Balyasnikova IV, et al. Among authors: lesniak ms. PLoS One. 2010 Mar 18;5(3):e9750. doi: 10.1371/journal.pone.0009750. PLoS One. 2010. PMID: 20305783 Free PMC article.

10

Crossing the boundaries: stem cells and gene therapy.

Ferguson SD, Ahmed AU, Thaci B, Mercer RW, Lesniak MS. Ferguson SD, et al. Among authors: lesniak ms. Discov Med. 2010 Mar;9(46):192-6. Discov Med. 2010. PMID: 20350484 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters